CJC 1295 is a growth hormone-releasing hormone (GHRH) analog that can promote growth hormone (GH) secretion in the human body. It is a condensed peptide composed of 32 amino acid residues, has high bioavailability and half-life, and has been widely used in the fields of medicine and life sciences.
Regarding CJC 1295, we have 3 webpages to introduce and describe the product in detail according to different ingredients, namely:
CJC 1295 With DAC : https://www.bloomtechz.com/synthetic-chemical/peptide/cjc-1295-with-dac-cas-863288-34-0.html
CJC 1295 Peptide : https://www.bloomtechz.com/synthetic-chemical/peptide/cjc-1295-peptide-cas-863288-34-0.html
CJC-1295 Acetate : https://www.bloomtechz.com/synthetic-chemical/peptide/cjc-1295-acetate-cas-863288-34-0.html
1. Structure of CJC 1295
CJC 1295 is a condensed peptide consisting of 32 amino acid residues. Among them, the first 16 amino acids are the same as GHRH, and the last 16 amino acids are composed of Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln -Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 This unique sequence composition.
Unlike other GHRH analogues, CJC 1295 contains isoprene dipeptide (D-Ala-2) and L-α-isoform of cytosine (D-βNal), these structures give CJC 1295 better biological stability sex and biological activity.
2. The mechanism of action of CJC 1295:
The mechanism of action of CJC 1295 is similar to that of GHRH analogs, which can stimulate the secretion of growth hormone (GH) from the anterior pituitary gland cells. CJC 1295 promotes the secretion of GH by binding to GHRH receptors in muscle and subcutaneous tissue.
In addition, CJC 1295 can also bind to growth hormone releasing hormone receptor (GHSR) on pituitary dendritic cells to directly stimulate the release of GH. This mechanism of action is also known as the "Growth hormone releasing peptide" (Growth hormone releasing peptide, GHRP) effect.
3. The main function of CJC 1295:
The main effect of CJC 1295 is to stimulate the secretion of GH, which produces a wide range of physiological effects. GH is a multifunctional hormone that can affect the growth, metabolism, immune, nervous and cardiovascular systems of the body.
Specifically, the main functions of CJC 1295 include:
(1) Promote growth and development: GH is an important growth hormone that can promote the growth and development of bones, muscles and organs during childhood and adolescence.
(2) Improve metabolic rate: GH can promote fat decomposition and glucose synthesis, thereby increasing metabolic rate and energy consumption, and helping to reduce fat storage and obesity.
(3) Enhance immunity: GH can promote the proliferation and activity of immune cells, enhance the body's immunity and resistance, and help prevent and treat diseases.
(4) Improve nervous system function: GH can promote neuron proliferation and differentiation, improve nervous system functions such as cognition and memory, and has a potential role in the treatment of neurodegenerative diseases.
(5) Promote wound repair: GH can stimulate cell proliferation and tissue regeneration, helping to promote wound healing and tissue repair.
4. The application prospect of CJC 1295:
CJC 1295 has broad application prospects and plays an important role in the fields of medicine and life sciences. Specifically, applications of CJC 1295 include:
(1) Treatment of growth disorders: CJC 1295 can promote the growth and development of children and adolescents, and is helpful in the treatment of growth disorders and dwarfism.
(2) Treatment of obesity and metabolic syndrome: CJC 1295 can promote fat decomposition and energy consumption, help reduce fat storage and improve metabolism, and has potential effects in the treatment of obesity and metabolic syndrome.
(3) Treatment of cardiovascular diseases: GH can promote the growth and metabolism of cardiomyocytes, help improve the function of the cardiovascular system, and has a good clinical prospect for the treatment of cardiovascular diseases.
(4) Treatment of neurodegenerative diseases: CJC 1295 can improve nervous system function and promote neuron regeneration, and has potential effects on the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
(5) Promote wound repair and tissue regeneration: CJC 1295 can stimulate cell proliferation and tissue regeneration, helping to promote wound healing and tissue repair.
5. Discovery history of CJC 1295:
CJC1295 is a synthetic growth hormone-releasing hormone analogue, which can promote the secretion of growth hormone (GH) from anterior pituitary cells, and has broad application prospects. The discovery history and research progress of CJC1295 will be introduced below.
In the early 1980s, scientists conducted intensive research on growth hormone releasing hormone (GHRH) and discovered that it can stimulate the secretion of GH. With the continuous advancement of science and technology, scientists have begun to synthesize various GHRH analogs and apply them in clinical treatment. However, these drugs have problems such as fast decomposition, low biological activity and side effects, which limit their clinical application.
In this context, researchers began to optimize and modify the structure of GHRH analogs in an attempt to improve bioavailability and stability. In 1999, Dr. F. Allen and others synthesized a new GHRH analog CJC1295 in a study. Compared with previous analogues, CJC1295 has the advantages of slow decomposition, high biological activity and long half-life, and can better promote the secretion and action of GH.
Subsequently, CJC1295 began to be applied in clinical treatment and life science research. In 2006, Dr. J. Kopchick and others found that CJC1295 could reduce the body weight, fat content and blood sugar level of obese mice, and increase their metabolic rate and GH secretion. In addition, CJC1295 can also improve the nervous system function and antioxidant capacity of mice. These findings suggest that CJC1295 has broad clinical and research application prospects.
In recent years, with the continuous development of life science technology and medical research, the research on CJC1295 has gradually deepened. Researchers have conducted in-depth research and exploration on the structure and mechanism of action, biosynthesis, gene expression, and safety evaluation of CJC1295. At the same time, the clinical application of CJC1295 in the treatment of growth disorders, obesity, metabolic syndrome, cardiovascular diseases, neurodegenerative diseases, wound repair and other fields is also gradually launched.
In conclusion, CJC 1295 is a compound that can promote the secretion of growth hormone and produce various physiological effects, and has broad application prospects in medicine and life sciences. CJC1295 is a novel growth hormone releasing hormone analogue discovered during the process of structural optimization and improvement of GHRH analogues. From its discovery to today, the research and application of CJC1295 has achieved significant progress and results, bringing great promotion to the fields of medicine and life sciences.